5 Equine Researchers Receive Boehringer Grants



Published:

Studies funded through the Advancement of Equine Research Awards are selected based on their potential impact on the equine industry, originality and scientific quality, and probability of success.

Drug maker Boehringer Ingelheim Vetmedica Inc. has awarded $15,000 grants to five university professors under the 2013 Advancement of Equine Research Awards program.

The grants, announced Monday during the American Association of Equine Practitioners conference in Nashville, Tenn., will go toward studies into the diagnosis, pathogenesis, transmission, control or prevention of equine infectious diseases.

An independent panel of equine practitioners, university professors and veterinary medicine researchers selected the recipients.

"Infectious diseases are an ongoing challenge for equine practitioners and horse owners, which is why they have always been a high priority for our company,” said Steve Grubbs, DVM, Ph.D., Dipl. ACVIM, an equine technical manager at Boehringer Ingelheim.

The grant recipients and their research topics are:

  • Noah Cohen, VMD, MPH, Ph.D., Dipl. ACVIM, a professor at Texas A&M University, for "Is Diversity of the Fecal Microbiome Associated With Risk of Rhodoccocus Equi Foal Pneumonia?”
     
  • Nicola Pusterla, DVM, Ph.D., Dipl. ACVIM, a professor at the University of California, Davis, for "Investigation of the Presence of Novel Viruses in Nasal secretions of Horses With Infectious Upper Respiratory Tract Disease.”
     
  • David Horohov, Ph.D., a professor at the University of Kentucky, for "Subisotypic Differences in the Immunoglobulin G Response to Lawsonia intracellularis in Vaccinated, Seropositive and Clinically Affected Horses.”
     
  • Ramiro E. Toribio, DVM, Ph.D., Dipl. ACVIM, an associate professor at Ohio State University, for "Dynamics of the Equine Fecal Microbiome in Response to Antibiotics.”
     
  • Ashely G. Boye, DVM, Dipl. ACVIM, an assistant professor of medicine at the University of Pennsylvania, for "Determining Optimal Sampling Site for Strangles Carriers Using Loop-mediated Isothermal (LAMP) PCR.”

Veterinarians, diagnosticians and public and private researchers in the United States and Canada may apply for the 2014 awards. More information is available at EquineDiseaseResearch.com.

Boehringer Ingelheim has issued $225,000 in Advancement of Equine Research Awards over the past three years.

The company is based in Ingelheim, Germany, and has U.S. headquarters in Ridgefield, Conn.

<HOME>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Jaguar Seeks Limited Approval of Canine Diarrhea Drug

San Francisco drug maker requests minor-use minor-species (MUMS) status for Canalevia.

FDA Approves Equine Lameness Drug

Tildren (tiludronate disodium) is an intravenous solution for the treatment of the most common cause of chronic forelimb lameness in horses.

AVMA Slams Investigation of Veterinary Industry

National organization says a series published in The Indianapolis Star impugns veterinarians and calls into question their integrity and professionalism.
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module